Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia

Cornea

Volumn 22, Issue 5, 2003, Pages 473-477

  Jin, Ji ^a   Guan, Ming ^b   Sima, Jing ^c   Gao, Guoquan ^d   Zhang, Mei ^e   Liu, Zhuguo ^e   Fant, James ^c   Ma, Jian Xing ^c  

^a Jinhua Central Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Conjunctiva; Corneal epithelium; Growth factor; Immunocytochemistry

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA LIMBUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PTERYGIUM; WESTERN BLOTTING;

CASE-CONTROL STUDIES; ENDOTHELIAL GROWTH FACTORS; EYE PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NERVE GROWTH FACTORS; PROTEINS; PTERYGIUM; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038312077     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200307000-00015     Document Type: Article

References (22)

1. Wong WW. A hypothesis on the pathogenesis of pterygiums. Ann Ophthalmol. 1978;10:303-308.
2. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
3. Hill JC, Maske R. Pathogenesis of pterygium. Eye. 1989;3:218-226.
4. Cameron ME. Histology of pterygium: an electron microscopic study. Br J Ophthalmol. 1983;67:604-608.
5. Cilova-Atanasova B. On the pathogenesis of pterygium. Folia Med (Plovdiv). 1971;13:67-74.
6. Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235-1240.
7. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem. 1996;98:195-201.
8. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998;236:702-708.
9. Powers MR, Qu Z, O'Brien B, et al. Immunolocalization of bFGF in pterygia: association with mast cells. Cornea. 1997;16:545-549.
10. Lee DH, Cho HJ, Kim JT, et al. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001;20:738-742.
11. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
12. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
13. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245-248.
14. Karakousis PC, John SK, Behling KC, et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis. 2001;7:154-163.
15. Gao GQ, Li Y, Zhang DC, et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001;489:270-276.
16. Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 2001;50:2641-2645.
17. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci. 2001;42:1963-1968.
18. Jimenez B, Volpert OV. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med. 2001;78:663-672.
19. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997;151:13-23.
20. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996;114:1219-1228.
21. Zhang D, Kaufman PL, Gao G, et al. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia. 2001;44:757-765.
22. Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43:821-829.